2023年6月最新SCI影响因子数据已经更新，欢迎查询！ 如果您对期刊系统有任何需求或者问题，欢迎反馈给我们。
 |
| 基本信息 | 登录收藏 | |||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名字 | JAPANESE JOURNAL OF CLINICAL ONCOLOGY JPN J CLIN ONCOL （此期刊被最新的JCR期刊SCIE收录） LetPub评分 5.2
50人评分
我要评分
声誉 6.3 影响力 3.9 速度 7.0 | |||||||||||||||||||||||||
| 期刊ISSN | 0368-2811 | 微信扫码收藏此期刊 | ||||||||||||||||||||||||
| E-ISSN | 1465-3621 | |||||||||||||||||||||||||
| 2022-2023最新影响因子 （数据来源于搜索引擎） | 2.4 点击查看影响因子趋势图 | |||||||||||||||||||||||||
| 实时影响因子 | 截止2023年9月27日：1.062 | |||||||||||||||||||||||||
| 2022-2023自引率 | 8.30%点击查看自引率趋势图 | |||||||||||||||||||||||||
| 五年影响因子 | 2.6 | |||||||||||||||||||||||||
| h-index | 79 | |||||||||||||||||||||||||
| CiteScore |
| |||||||||||||||||||||||||
| 期刊简介 | Japanese Journal of Clinical Oncology is a multidisciplinary journal for clinical oncologists which strives to publish high quality manuscripts addressing medical oncology, clinical trials, radiology, surgery, basic research, and palliative care. The journal aims to contribute to the world"s scientific community with special attention to the area of clinical oncology and the Asian region. JJCO publishes various articles types including: ・Original Articles ・Case Reports ・Clinical Trial Notes ・Cancer Genetics Reports ・Epidemiology Notes ・Technical Notes ・Short Communications ・Letters to the Editors ・Solicited Reviews | |||||||||||||||||||||||||
| 期刊官方网站 | https://academic.oup.com/jjco | |||||||||||||||||||||||||
| 期刊投稿网址 | http://mc.manuscriptcentral.com/jjco | |||||||||||||||||||||||||
| 期刊语言要求 | 经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件，不仅能满足JAPANESE JOURNAL OF CLINICAL ONCOLOGY的语言要求，还能让JAPANESE JOURNAL OF CLINICAL ONCOLOGY编辑和审稿人得到更好的审稿体验，让稿件最大限度地被JAPANESE JOURNAL OF CLINICAL ONCOLOGY编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务（包括SCI论文英语润色，同行资深专家修改润色，SCI论文专业翻译，SCI论文格式排版，专业学术制图等）帮助作者准备稿件，已助力全球15万+作者顺利发表论文。部分发表范例可查看：服务好评 论文致谢 。
提交文稿 | |||||||||||||||||||||||||
| 是否OA开放访问 | No | |||||||||||||||||||||||||
| 通讯方式 | OXFORD UNIV PRESS, GREAT CLARENDON ST, OXFORD, ENGLAND, OX2 6DP | |||||||||||||||||||||||||
| 出版商 | Oxford University Press | |||||||||||||||||||||||||
| 涉及的研究方向 | 医学-肿瘤学 | |||||||||||||||||||||||||
| 出版国家或地区 | JAPAN | |||||||||||||||||||||||||
| 出版语言 | English | |||||||||||||||||||||||||
| 出版周期 | Monthly | |||||||||||||||||||||||||
| 出版年份 | 1971 | |||||||||||||||||||||||||
| 年文章数 | 180点击查看年文章数趋势图 | |||||||||||||||||||||||||
| Gold OA文章占比 | 15.81% | |||||||||||||||||||||||||
| 研究类文章占比： 文章 ÷（文章 + 综述） | 82.78% | |||||||||||||||||||||||||
| WOS期刊SCI分区 （ 2022-2023年最新版） | WOS分区等级：4区
| |||||||||||||||||||||||||
| 中科院《国际期刊预警 名单（试行）》名单 | 2023年01月发布的2023版：不在预警名单中 2021年12月发布的2021版：不在预警名单中 2021年01月发布的2020版：不在预警名单中 | |||||||||||||||||||||||||
| 中科院SCI期刊分区 （ 2022年12月最新升级版） | 点击查看中科院SCI期刊分区趋势图
| |||||||||||||||||||||||||
| 中科院SCI期刊分区 （ 2021年12月基础版） |
| |||||||||||||||||||||||||
| 中科院SCI期刊分区 （ 2021年12月升级版） |
| |||||||||||||||||||||||||
| 中科院SCI期刊分区 （ 2020年12月旧的升级版） |
| |||||||||||||||||||||||||
| SCI期刊收录coverage | Science Citation Index Expanded (SCIE) (2020年1月，原SCI撤销合并入SCIE，统称SCIE) Scopus (CiteScore) | |||||||||||||||||||||||||
| PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=0368-2811%5BISSN%5D | |||||||||||||||||||||||||
| 平均审稿速度 | 网友分享经验： 一般,3-8周 | |||||||||||||||||||||||||
| 平均录用比例 | 网友分享经验： 容易 | |||||||||||||||||||||||||
| LetPub助力发表 | 经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍，平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务（包括SCI论文英语润色，同行资深专家修改润色，SCI论文专业翻译，SCI论文格式排版，专业学术制图等）后论文在JAPANESE JOURNAL OF CLINICAL ONCOLOGY顺利发表。
快看看作者怎么说吧：服务好评 论文致谢 | |||||||||||||||||||||||||
| 期刊常用信息链接 |
| |||||||||||||||||||||||||
|
|
| |
| 中国学者近期发表的论文 | |
| 1. | Survival and clinicopathological significance of blood vessel invasion in operable breast cancer: a systematic review and meta-analysis Author: Lin, Yingxin; Zhang, Yuehua; Fang, Huiqiong; Hu, Qian; Duan, Haibo; Zhang, Liangyun; Pang, Danmei Journal: JAPANESE JOURNAL OF CLINICAL ONCOLOGY. 2023; Vol. 53, Issue 1, pp. 35-45. DOI: 10.1093/jjco/hyac149 PubMed DOI |
| 2. | Mesorectal excision with or without lateral lymph node dissection for elderly patients with mid-low rectal cancer: safety and feasibility analysis Author: Zhou, Sicheng; Mei, Shiwen; Feng, Bo; Yang, Yingchi; Wang, Xin; Wang, Quan; Liu, Qian Journal: JAPANESE JOURNAL OF CLINICAL ONCOLOGY. 2023; Vol. 53, Issue 1, pp. 26-34. DOI: 10.1093/jjco/hyac167 PubMed DOI |
| 3. | The effectiveness of consolidation chemotherapy in high-risk early-stage cervical cancer patients following concurrent chemoradiation after radical surgery Author: Wang, Cong; Fu, Chunli; Ma, Changdong; Qian, Qiuhong; He, Fangfang; Zhang, Guangyu Journal: JAPANESE JOURNAL OF CLINICAL ONCOLOGY. 2023; Vol. 53, Issue 2, pp. 122-129. DOI: 10.1093/jjco/hyac170 PubMed DOI |
| 4. | Pembrolizumab or pembrolizumab plus chemotherapy versus standard of care chemotherapy in patients with advanced gastric or gastroesophageal junction adenocarcinoma: Asian subgroup analysis of KEYNOTE-062 Author: Satake, Hironaga; Lee, Keun-Wook; Chung, Hyun Cheol; Lee, Jeeyun; Yamaguchi, Kensei; Chen, Jen-Shi; Yoshikawa, Takaki; Amagai, Kenji; Yeh, Kun-Huei; Goto, Masahiro; Chao, Yee; Lam, Ka-On; Han, Shi Rong; Shiratori, Shinichi; Shah, Sukrut; Shitara, Kohei Journal: JAPANESE JOURNAL OF CLINICAL ONCOLOGY. 2023; Vol. 53, Issue 3, pp. 221-229. DOI: 10.1093/jjco/hyac188 PubMed DOI |
| 5. | The efficacy and safety of trastuzumab deruxtecan (T-DXd) in HER2-expressing solid tumours: a single-arm meta-analysis Author: Kou, Liqiu; Chen, Xiu; Xie, Xiaolu; Wen, Qinglian; Li, Jun; Li, Yaling Journal: JAPANESE JOURNAL OF CLINICAL ONCOLOGY. 2023; Vol. , Issue , pp. -. DOI: 10.1093/jjco/hyad036 PubMed DOI |
| 6. | Individualized conditional survival nomograms for stage I-III early onset colorectal cancer patients Author: Chen, Min; Chen, Ting Journal: JAPANESE JOURNAL OF CLINICAL ONCOLOGY. 2023; Vol. 53, Issue 2, pp. 115-121. DOI: 10.1093/jjco/hyac169 PubMed DOI |
| 7. | HER2-low status may predict poor neoadjuvant chemotherapy response in HR-negative breast cancer: a real-world multicenter study Author: Xu, Weiwei; Jiang, Yunshan; Xu, Lingyun; Li, Changwen; Wang, Ji; Liu, Zhao; Xue, Dandan; Gu, Yanlin; Zhong, Zhaoyun; He, Shiqing; Wang, Shui; Zhou, Wenbin; Pan, Hong Journal: JAPANESE JOURNAL OF CLINICAL ONCOLOGY. 2023; Vol. , Issue , pp. -. DOI: 10.1093/jjco/hyad009 PubMed DOI |
| 8. | Metabolic-associated fatty liver disease and risk of esophagogastric cancer: a systematic review and meta-analysis Author: Zou, Qu; Tan, Hao-Yang; Li, Jun-Chi; Li, Ya-Dong; Yang, Kang Journal: JAPANESE JOURNAL OF CLINICAL ONCOLOGY. 2023; Vol. , Issue , pp. -. DOI: 10.1093/jjco/hyad038 PubMed DOI |
| 9. | Development and validation of a nomogram incorporating axillary lymph node ratio to predict survival in node-positive breast cancer patients after neoadjuvant chemotherapy. Author: Lai J1,2, Pan Z1,3, Chen P4, Ye G4, Chen K1,2, Su F1,2. Journal: Jpn J Clin Oncol. 2019 Jan 1;49(1):22-28. doi: 10.1093/jjco/hyy181. PubMed DOI |
| 10. | Prognostic index score predicts outcome of patients with Stage I non-small cell lung cancer after stereotactic body radiation therapy. Author: Shi S1, Ye L1, Zhao Q1, Hu Y1, Huang Y1, Chen G1, Zeng Z1, He J1. Journal: Jpn J Clin Oncol. 2019 Apr 1;49(4):367-372. doi: 10.1093/jjco/hyy205. PubMed DOI |
|
|
  | |
|
以上SCI期刊相关数据和信息来源于网络，仅供参考。
投稿状态统计： 我要评分： | |
同领域作者分享投稿经验：共0条 （包含回复） |
我来分享 |
|
|
联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们
© 2010-2023 中国: LetPub上海分公司 网站备案号：沪ICP备10217908号-1 
沪公网安备号：31010402006960
增值电信业务经营许可证：沪B2-20211595
礼翰商务信息咨询（上海）有限公司 办公地址：上海市徐汇区漕溪北路88号圣爱大厦2103室
United States: Tel: 1-781-202-9968 Address: 400 5th Ave, Suite 530, Waltham, Massachusetts 02451
安全保密
